Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
作者信息
Sperling M A
出版信息
West J Med. 1975 Jan;122(1):42-9.
Abstract
摘要
相似文献
1
Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.全身性口服避孕药治疗的并发症：肿瘤——乳腺、子宫、宫颈和阴道。
West J Med. 1975 Jan;122(1):42-9.
2
[Oral contraception and cancers of the uterus and the breast].[口服避孕药与子宫癌和乳腺癌]
J Gynecol Obstet Biol Reprod (Paris). 1974 Apr-May;3(3):379-400.
3
Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
Trans Pac Coast Obstet Gynecol Soc. 1972;40:15-29.
4
Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.年轻女性宫颈和阴道的透明细胞癌。6例与母亲孕期己烯雌酚治疗及阴道腺病相关的病例报告。
Am J Obstet Gynecol. 1973 Jun 15;116(4):470-84. doi: 10.1016/0002-9378(73)90903-4.
5
[The stilbestrol--adenosis--carcinoma--syndrome. A review].
Geburtshilfe Frauenheilkd. 1975 May;35(5):329-33.
6
Clear-cell adenocarcinoma of the genital tract in young females. Registry report.年轻女性生殖道透明细胞腺癌。登记报告。
N Engl J Med. 1972 Dec 21;287(25):1259-64. doi: 10.1056/NEJM197212212872501.
7
Cancer risks from estrogen intake.
N Y State J Med. 1977 Jun;77(7):1069-74.
8
Role of exogenous female hormones in altering the risk of benign and malignant neoplasms in humans.外源性女性激素在改变人类良性和恶性肿瘤风险中的作用。
Cancer Res. 1978 Nov;38(11 Pt 2):3991-4000.
9
Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.与产前接触己烯雌酚相关的阴道和宫颈异常，包括透明细胞腺癌。
Ann Clin Lab Sci. 1974 Jul-Aug;4(4):222-33.
10
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
J Med Assoc State Ala. 1977 Mar;46(9):39-41.
本文引用的文献
1
Hypertension associated with oral contraceptives.与口服避孕药相关的高血压
Can Med Assoc J. 1966 Jul 23;95(4):167.
2
ADENOSIS VAGINAE.阴道腺病
Am J Obstet Gynecol. 1965 Sep 15;93:209-22. doi: 10.1016/0002-9378(65)90660-5.
3
STUDIES OF HEPATIC EXCRETORY FUNCTION. II. THE EFFECT OF NORETHYNODREL AND MESTRANOL ON BROMSULFALIEN SODIUM METABOLISM IN WOMEN OF CHILDBEARING AGE.肝脏排泄功能的研究。II. 炔诺酮和炔雌醇甲醚对育龄妇女酚磺酞钠代谢的影响。
N Engl J Med. 1965 Aug 19;273:420-3. doi: 10.1056/NEJM196508192730804.
4
ORAL CONTRACEPTION AND LIVER-FUNCTION TESTS.口服避孕药与肝功能检查
Br Med J. 1965 May 29;1(5447):1414-5. doi: 10.1136/bmj.1.5447.1414.
5
ESTROGEN PHARMACOLOGY. I. THE INFLUENCE OF ESTRADIOL AND ESTRIOL ON HEPATIC DISPOSAL OF SULFOBROMOPHTHALEIN (BSP) IN MAN.雌激素药理学。一、雌二醇和雌三醇对人体肝脏排泄磺溴酞钠（BSP）的影响。
J Clin Invest. 1964 Oct;43(10):1905-14. doi: 10.1172/JCI105064.
6
EFFECTS OF ORAL OVULATION INHIBITORS ON SERUM PROTEIN-BOUND IODINE AND THYROXINE BINDING PROTEINS.口服排卵抑制剂对血清蛋白结合碘及甲状腺素结合蛋白的影响
Proc Soc Exp Biol Med. 1964 Oct;117:56-8. doi: 10.3181/00379727-117-29495.
7
CURRENT STATUS OF LOS ANGELES ORAL CONTRACEPTION STUDIES.
Appl Ther. 1964 Jun;6:507-11.
8
INHIBITORS OF GLUCURONYL TRANSFERASE IN THE NEWBORN.新生儿中葡萄糖醛酸基转移酶的抑制剂
Ann N Y Acad Sci. 1963 Dec 30;111:326-36. doi: 10.1111/j.1749-6632.1963.tb36975.x.
9
ALTERATIONS IN SULFOBROMOPHTHALEIN SODIUM-REMOVAL MECHANISMS FROM BLOOD DURING NORMAL PREGNANCY.正常妊娠期间血液中磺溴酞钠清除机制的改变。
J Clin Invest. 1963 Sep;42(9):1431-42. doi: 10.1172/JCI104828.
10
Effectiveness of estrogens for therapy of myocardial infarction in middle-age men.雌激素对中年男性心肌梗死的治疗效果。
JAMA. 1963 Feb 23;183:632-8. doi: 10.1001/jama.1963.03700080040013.
Zotero 插件